Your browser doesn't support javascript.
Health-related quality of life and hospitalizations in chronic thromboembolic pulmonary hypertension versus idiopathic pulmonary arterial hypertension: an analysis from the Pulmonary Hypertension Association Registry (PHAR).
Minhas, Jasleen; Narasimmal, Sai Prasanna; M Bull, Todd; Marco, Teresa De; McConnell, John Wesley; Lammi, Matthew R; Thenappan, Thenappan; P Feldman, Jeremy; S Sager, Jeffrey; B Badesch, David; Ryan, John J; C Grinnan, Daniel; Zwicke, Dianne; M Horn, Evelyn; Elwing, Jean M; Moss, John E; Eggert, Michael; Shlobin, Oksana A; P Frantz, Robert; D Bartolome, Sonja; Mathai, Stephen C; Mazimba, Sula; C Pugliese, Steven; Al-Naamani, Nadine.
  • Minhas J; Division of Pulmonary, Allergy and Critical Care Medicine, University of Pennsylvania, Philadelphia, PA, USA.
  • Narasimmal SP; Division of Pulmonary, Allergy and Critical Care Medicine, University of Pennsylvania, Philadelphia, PA, USA.
  • M Bull T; Division of Pulmonary Sciences & Critical Care, University of Colorado, Denver, CO, USA.
  • Marco T; Division of Cardiology, University of California, San Francisco, CA, USA.
  • McConnell JW; Norton Healthcare, Louisville, KY, USA.
  • Lammi MR; Division of Pulmonary and Critical Care Medicine, Louisiana State University, New Orleans, LO, USA.
  • Thenappan T; Division of Cardiology, University of Minnesota, Minneapolis, MN, USA.
  • P Feldman J; Division of Pulmonary and Critical Care Medicine, Arizona Pulmonary Specialists, Phoenix, AZ, USA.
  • S Sager J; Division of Pulmonary and Critical Care Medicine, Cottage PH center, Santa Barbara, CA, USA.
  • B Badesch D; Division of Pulmonary Sciences & Critical Care, University of Colorado, Denver, CO, USA.
  • Ryan JJ; Division of Cardiology, University of Utah, Salt Lake City, UT, USA.
  • C Grinnan D; Division of Pulmonary and Critical Care Medicine, Virginia Commonwealth University, Richmond, VA, USA.
  • Zwicke D; Division of Cardiology, Aurora Cardiovascular Services, Milwaukee, WI, USA.
  • M Horn E; Division of Cardiology, Weill Conrell Medicine, New York City, NY, USA.
  • Elwing JM; Division of Pulmonary and Critical Care Medicine, University of Cincinnati, Cincinnati, OH, USA.
  • Moss JE; Department of Pulmonary Medicine and Division of Critical Care, Mayo Clinic, Jacksonville, FL, USA.
  • Eggert M; Division of Pulmonary and Critical Care Medicine, Sentara Hospital, Norfolk, VA, USA.
  • Shlobin OA; Division of Pulmonary and Critical Care Medicine, Inova Fairfax Hospital, Advanced Lung Disease and Transplant, Falls Church, VA, USA.
  • P Frantz R; Department of Cardiovascular Diseases, Mayo Clinic, Rochester, MN, USA.
  • D Bartolome S; Division of Pulmonary and Critical Care Medicine, University of Texas, Southwestern Medical Center, Dallas, TX, USA.
  • Mathai SC; Division of Pulmonary and Critical Care Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Mazimba S; Division of Cardiology, University of Virginia Health System, Charlottesville, VA, USA.
  • C Pugliese S; Division of Pulmonary, Allergy and Critical Care Medicine, University of Pennsylvania, Philadelphia, PA, USA.
  • Al-Naamani N; Division of Pulmonary, Allergy and Critical Care Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Pulm Circ ; 11(4): 20458940211053196, 2021.
Article in English | MEDLINE | ID: covidwho-1496097
ABSTRACT
Chronic thromboembolic pulmonary hypertension (CTEPH) is a rare, morbid, potentially curable subtype of pulmonary hypertension that negatively impacts health-related quality of life (HRQoL). Little is known about differences in HRQoL and hospitalization between CTEPH patients and idiopathic pulmonary arterial hypertension (IPAH) patients. Using multivariable linear regression and mixed effects models, we examined differences in HRQoL assessed by emPHasis-10 (E10) and SF-12 between CTEPH and IPAH patients in the Pulmonary Hypertension Association Registry, a prospective multicenter cohort of patients newly evaluated at a Pulmonary Hypertension Care Center. Multivariable negative binomial regression models were used to estimate incidence rate ratios (IRR) for hospitalization amongst the two groups. We included 461 IPAH patients and 169 CTEPH patients. Twenty-one percent of CTEPH patients underwent pulmonary thromboendarterectomy (PTE) before the end of follow-up. At baseline, patients with CTEPH had significantly worse HRQoL (higher E10 scores) (ß 2.83, SE 1.11, p = 0.01); however, differences did not persist over time. CTEPH patients had higher rates of hospitalization (excluding the hospitalization for PTE) compared to IPAH patients after adjusting for age, sex, body mass index, WHO functional class and six-minute walk distance (IRR 1.66, 95%CI 1.04-2.65, p = 0.03). CTEPH patients who underwent PTE had improved HRQoL as compared to those who were medically managed, but patients who underwent PTE were younger, had higher cardiac outputs and greater six-minute walk distances. In this large, prospective, multicenter cohort, CTEPH patients had significantly worse baseline HRQoL and higher rates of hospitalizations than those with IPAH. CTEPH patients who underwent PTE had significant improvements in HRQoL.
Keywords

Full text: Available Collection: International databases Database: MEDLINE Type of study: Cohort study / Experimental Studies / Observational study / Prognostic study / Randomized controlled trials Language: English Journal: Pulm Circ Year: 2021 Document Type: Article Affiliation country: 20458940211053196

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Type of study: Cohort study / Experimental Studies / Observational study / Prognostic study / Randomized controlled trials Language: English Journal: Pulm Circ Year: 2021 Document Type: Article Affiliation country: 20458940211053196